AREMA is proud to have taken part in the 24th edition of FPI Tunis 2025 event (Forum Pharmaceutique International). FPI Tunis 2025 is a remarkable, huge […]
On April 16, 2025, AREMA will participate in the A3P Tunisia Forum, in partnership with Extedo. This forum is about: e-CTD / The new global guidelines […]
Tunisian National Agency for Medicines and Health Products (ANMPS) issued an urgent and important note by 10 April 2025 reminding all pharmaceutical companies to comply with pharmacovigilance […]
In an effort to enhance efficiency and transparency, the Algerian National Agency for Pharmaceutical Products (ANPP) has introduced key digitalization initiatives for the regulatory processes related […]
On January 6, 2025, the International Council for Harmonisation (ICH) adopted the ICH E6(R3) Guideline, introducing significant advancements in Good Clinical Practice (GCP). This updated guideline […]
Senegal and Rwanda have reached a significant milestone by achieving the World Health Organization’s (WHO) Maturity Level 3 in medicines regulation. This status reflects their capabilities […]
In a landmark move, African nations are coming together to address healthcare challenges by establishing a consolidated medicines and vaccines supply network. This initiative, unveiled during […]
The statement regarding the implementation of eCTD has just been published officially by the National Agency for Medicines and Health Products (ANMPS) on the 28th of June 2024.Tunisia is […]
The European Medicines Agency has updated the ICH Q2(R2) Guideline on validation of analytical procedures. The update final adoption was in December 2023 and will come […]